I Taylor

1.3k total citations
34 papers, 952 citations indexed

About

I Taylor is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, I Taylor has authored 34 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in I Taylor's work include Protein Degradation and Inhibitors (14 papers), Peptidase Inhibition and Analysis (7 papers) and Prostate Cancer Treatment and Research (7 papers). I Taylor is often cited by papers focused on Protein Degradation and Inhibitors (14 papers), Peptidase Inhibition and Analysis (7 papers) and Prostate Cancer Treatment and Research (7 papers). I Taylor collaborates with scholars based in United States, United Kingdom and Australia. I Taylor's co-authors include Ryan R. Willard, John Houston, Jennifer Pizzano, Mark Bookbinder, Andrew P. Crew, Craig M. Crews, Lawrence B. Snyder, Taavi K. Neklesa, Nicholas Vitale and Jennifer Macaluso and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Radiology.

In The Last Decade

I Taylor

34 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Taylor United States 13 575 336 169 110 90 34 952
Tsunehiro Shimizu Japan 16 747 1.3× 437 1.3× 55 0.3× 75 0.7× 88 1.0× 40 1.2k
Xiaoya Ma China 14 343 0.6× 125 0.4× 133 0.8× 73 0.7× 25 0.3× 27 810
A. Wunderlich Germany 14 226 0.4× 158 0.5× 45 0.3× 59 0.5× 23 0.3× 21 791
Woo‐Yoon Park South Korea 20 331 0.6× 187 0.6× 17 0.1× 149 1.4× 31 0.3× 67 947
Yushe Dang United States 19 343 0.6× 651 1.9× 19 0.1× 66 0.6× 62 0.7× 45 1.3k
N Génetet France 18 261 0.5× 205 0.6× 140 0.8× 48 0.4× 16 0.2× 54 1.0k
R. N. Taub United States 15 235 0.4× 206 0.6× 36 0.2× 168 1.5× 20 0.2× 35 819
Makoto Monnai Japan 14 361 0.6× 155 0.5× 56 0.3× 36 0.3× 12 0.1× 22 810
Harold H.J. Backus Netherlands 17 595 1.0× 609 1.8× 25 0.1× 258 2.3× 16 0.2× 23 1.3k

Countries citing papers authored by I Taylor

Since Specialization
Citations

This map shows the geographic impact of I Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Taylor more than expected).

Fields of papers citing papers by I Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Taylor. The network helps show where I Taylor may publish in the future.

Co-authorship network of co-authors of I Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of I Taylor. A scholar is included among the top collaborators of I Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Taylor. I Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeCarr, Lynn B., Elizabeth Bortolon, Mark Bookbinder, et al.. (2025). Abstract 1655: ARV-393, a PROTAC B-cell lymphoma 6 (BCL6) degrader, combined with biologics or small molecule inhibitors (SMIs) induces tumor regressions in diffuse large B-cell lymphoma (DLBCL) models. Cancer Research. 85(8_Supplement_1). 1655–1655. 1 indexed citations
2.
Wu, Wendy, Monica Andreoli, Elizabeth Bortolon, et al.. (2023). Abstract 432: Mechanisms of acquired resistance to ARV-471, a novel PROTAC® estrogen receptor degrader. Cancer Research. 83(7_Supplement). 432–432. 3 indexed citations
3.
Snyder, Larry, Taavi K. Neklesa, Xin Chen, et al.. (2023). Abstract ND03: Discovery of ARV-766, an androgen receptor degrading PROTAC® for the treatment of men with metastatic castration resistant prostate cancer. Cancer Research. 83(7_Supplement). ND03–ND03. 12 indexed citations
4.
Petrylak, Daniel P., Xīn Gào, Nicholas J. Vogelzang, et al.. (2020). First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).. Journal of Clinical Oncology. 38(15_suppl). 3500–3500. 119 indexed citations
5.
Neklesa, Taavi K., Lawrence B. Snyder, Ryan R. Willard, et al.. (2018). An oral androgen receptor PROTAC degrader for prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 381–381. 14 indexed citations
6.
Hawkins, Michelle G., et al.. (2018). PHARMACOKINETICS OF CEFTIOFUR CRYSTALLINE FREE ACID STERILE SUSPENSION IN GREEN IGUANAS (IGUANA IGUANA) AFTER SINGLE INTRAMUSCULAR ADMINISTRATION. Journal of Zoo and Wildlife Medicine. 49(1). 86–91. 5 indexed citations
7.
Taylor, I, et al.. (2017). Acute urinary retention after Black Widow envenomation: a case report. Canadian Journal of Emergency Medicine. 20(4). 640–642. 3 indexed citations
8.
Neklesa, Taavi K., Lawrence B. Snyder, Mark Bookbinder, et al.. (2017). An oral androgen receptor PROTAC degrader for prostate cancer.. Journal of Clinical Oncology. 35(6_suppl). 273–273. 23 indexed citations
9.
Taylor, I, et al.. (2014). Does rapid assessment shorten the amount of time patients spend in the emergency department?. British Journal of Hospital Medicine. 75(11). 648–651. 10 indexed citations
10.
Hawkins, Michelle G., I Taylor, Barbara A. Byrne, Ray Armstrong, & Lisa A. Tell. (2010). Pharmacokinetic–pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration. Journal of Veterinary Pharmacology and Therapeutics. 34(4). 350–358. 11 indexed citations
11.
Hawkins, Michelle G., et al.. (2009). Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures. American Journal of Veterinary Research. 70(7). 908–914. 5 indexed citations
12.
Hawkins, Michelle G., et al.. (2008). Pharmacokinetics of butorphanol tartrate in red-tailed hawks (Buteo jamaicensis) and great horned owls (Bubo virginianus). American Journal of Veterinary Research. 69(5). 596–603. 40 indexed citations
13.
Hawkins, Michelle G., I Taylor, Arthur L. Craigmill, & Lisa A. Tell. (2008). Enantioselective pharmacokinetics of racemic carprofen in New Zealand white rabbits. Journal of Veterinary Pharmacology and Therapeutics. 31(5). 423–430. 8 indexed citations
14.
Lane, V. Michael, Aurora Villarroel, Scott E. Wetzlich, et al.. (2007). Tissue residues of florfenicol in sheep. Journal of Veterinary Pharmacology and Therapeutics. 31(2). 178–180. 12 indexed citations
15.
Hawkins, Michelle G., et al.. (2006). Drug distribution and stability in extemporaneous preparations of meloxicam and carprofen after dilution and suspension at two storage temperatures. Journal of the American Veterinary Medical Association. 229(6). 968–974. 4 indexed citations
16.
Lane, V. Michael, et al.. (2004). Intravenous and subcutaneous pharmacokinetics of florfenicol in sheep. Journal of Veterinary Pharmacology and Therapeutics. 27(4). 191–196. 31 indexed citations
17.
Drew, Mark L., et al.. (2004). Pharmacokinetics of ceftiofur in llamas and alpacas. Journal of Veterinary Pharmacology and Therapeutics. 27(1). 13–20. 19 indexed citations
18.
Douek, Michael, Margaret Hall‐Craggs, Elizabeth Benjamin, et al.. (1997). Contrast enhancement MRI and tumour angiogenesis in breast cancer. UCL Discovery (University College London). 1 indexed citations
19.
Mumtaz, Hamid, Margaret Hall‐Craggs, AC Wotherspoon, et al.. (1996). Laser therapy for breast cancer: MR imaging and histopathologic correlation.. Radiology. 200(3). 651–658. 107 indexed citations
20.
McDonald, P. J., Rob E. Carpenter, G T Royle, & I Taylor. (1990). Poor response of breast cancer to tamoxifen. Postgraduate Medical Journal. 66(782). 1029–1031. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsunehiro Shimizu Breakdown of academic impact, for papers by Xiaoya Ma Breakdown of academic impact, for papers by A. Wunderlich Breakdown of academic impact, for papers by Woo‐Yoon Park Breakdown of academic impact, for papers by Yushe Dang Breakdown of academic impact, for papers by N Génetet Breakdown of academic impact, for papers by R. N. Taub Breakdown of academic impact, for papers by Makoto Monnai Breakdown of academic impact, for papers by Harold H.J. Backus
Rankless by CCL
2026